Status:
COMPLETED
Group Depression Treatment for Autistic Youth
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Autism Spectrum Disorder
Depression
Eligibility:
All Genders
11-17 years
Phase:
NA
Brief Summary
Higher rates of depression are reported by autistic adolescents as compared to their non-autistic peers, which is problematic given adverse outcomes (e.g., negative self-esteem, lower academic perform...
Detailed Description
Higher rates of depression and suicidal thoughts are reported by autistic adolescents as compared to their non-autistic peers, which is problematic given adverse outcomes (e.g., negative self-esteem, ...
Eligibility Criteria
Inclusion
- Adolescent
- 11 to 17 years of age (middle or high school)
- Diagnosis of Autism Spectrum Disorder
- Average to above-average intellectual functioning
- Willing to attend study visits and participate in weekly group intervention
- Adolescent
Exclusion
- No diagnosis of Autism Spectrum Disorder
- Comorbid intellectual impairment (FSIQ \< 70), as the study protocol and assessments are not designed, and thus not appropriate, for this population.
- Severe medical conditions (e.g., uncontrolled seizures) and/or genetic disorders (e.g., Fragile X syndrome).
- Unwilling to attend study visits or weekly group intervention sessions.
- Significant aggression to self/others
- Significant active suicidal thoughts with intent/plan requiring higher-level care
- Parent Inclusion Criteria:
- At least 18 years of age and a parent or legal guardian of the adolescent participant with ASD.
- Able to provide current and historical observations of the functioning of the participant with ASD based on self report from parent. Similarly, parent must live in close proximity to and have frequent contact with the participant with ASD.
- Willing to complete questionnaires about their own functioning and that of their child with ASD.
- Parent
Key Trial Info
Start Date :
July 21 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 3 2023
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05430022
Start Date
July 21 2021
End Date
April 3 2023
Last Update
November 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212